For more updates follow Grant Thornton Bharat on WhatsApp
Filter insights by:
Filters applied:
India’s pharma and healthcare sector remained active in Q3 2026 as organisations advanced consolidation, regional expansion and capability-building agendas.
The consumer and retail sector saw investors become more selective in Q3 2026, with capital favouring differentiated brands, category leaders and scalable business models. Public markets emerged as an important funding avenue, while premiumisation remained a key investment theme across consumer segments. The Q3 2026 edition of the Consumer and Retail Dealtracker analyses deal activity across M&A, private equity, venture capital and public markets, and highlights the trends influencing investment decisions across the sector.
India’s real estate sector continued to attract investor interest in Q3 2026, driven by domestic participation, private equity investments and demand for income-generating assets. Investors remained focused on quality opportunities across key segments, supporting transaction activity despite a selective investment environment.
The current conflict involving the United States, Israel and Iran has disrupted one of the world's most critical energy and maritime corridors: the Strait of Hormuz.
India's automotive sector recorded strong deal activity in Q3 2026, driven by higher M&A activity, increased private equity investment and renewed capital markets fundraising. Investors continued to back electrification, mobility platforms and automotive technology businesses, reinforcing confidence in the sector's long-term growth prospects.
Financial services dealmaking reflected a measured investment approach, with investors placing greater emphasis on scale, profitability and regulatory resilience. Interest remained strong across several segments of the sector, particularly where technology and business fundamentals aligned.
India’s dealmaking market sustained momentum in the third quarter as investors, corporates and funds pursued strategic opportunities across sectors.
Deal activity remained strong during August, with M&A and PE together reflecting healthy transaction activity and a notable return of large-ticket PE investments.
July 2026 saw dealmaking regain momentum, led by large-ticket M&A transactions and stronger cross-border activity.
In Q2 2026, pharma and healthcare deal activity reflected a selective investment environment. Strategic acquisitions, portfolio strengthening and capability-led expansion remained key themes across the sector.
India's real estate industry recorded stronger transaction activity during the quarter. Domestic activity, capital market fundraising and investor interest in income-generating assets continued to support market activity.
The consumer and retail sector witnessed sustained investment interest as businesses strengthened category leadership, expanded portfolios and pursued differentiated growth opportunities.
The second quarter of 2026 reflected more selective capital allocation, with investors backing differentiated technology and scalable business models. The Q2 2026 edition of the Automotive Dealtracker analyses mergers and acquisitions, private equity and public market activity, highlighting key deal trends across mobility platforms, automotive technology and the EV ecosystem.
The April edition of the Monthly Dealtracker presents a consolidated view of transaction activity across mergers and acquisitions, private equity and public markets.
India’s dealmaking environment continued to demonstrate resilience in May 2026, supported by sustained activity across mergers and acquisitions, private equity, and public markets.
The April edition of the Monthly Dealtracker presents a consolidated view of transaction activity across mergers and acquisitions, private equity and public markets.